| __timestamp | Gilead Sciences, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 2854000000 | 242549000 |
| Thursday, January 1, 2015 | 3014000000 | 245098000 |
| Friday, January 1, 2016 | 5098000000 | 147600000 |
| Sunday, January 1, 2017 | 3734000000 | 264600000 |
| Monday, January 1, 2018 | 5018000000 | 357900000 |
| Tuesday, January 1, 2019 | 9106000000 | 1182600000 |
| Wednesday, January 1, 2020 | 5039000000 | 357700000 |
| Friday, January 1, 2021 | 5363000000 | 540100000 |
| Saturday, January 1, 2022 | 4977000000 | 322900000 |
| Sunday, January 1, 2023 | 6923000000 | 408000000 |
| Monday, January 1, 2024 | 5907000000 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is the lifeblood of success. Gilead Sciences, Inc. and United Therapeutics Corporation are two titans in this arena, each with a distinct approach to research and development (R&D) investment. From 2014 to 2023, Gilead Sciences consistently outpaced United Therapeutics in R&D spending, with an average annual investment nearly 12 times greater. Notably, in 2019, Gilead's R&D expenses surged to a peak, marking a 220% increase from 2014. Meanwhile, United Therapeutics showed a steady, albeit smaller, growth in R&D investment, peaking in 2019 with a 388% increase from its 2014 figures. This disparity highlights Gilead's aggressive strategy in pioneering new treatments, while United Therapeutics maintains a more measured approach. As the biotech landscape evolves, these investment patterns may shape the future of medical breakthroughs.
AstraZeneca PLC or United Therapeutics Corporation: Who Invests More in Innovation?
Comparing Innovation Spending: Pfizer Inc. and Gilead Sciences, Inc.
Gilead Sciences, Inc. vs GSK plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Gilead Sciences, Inc. and Alkermes plc
Gilead Sciences, Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How argenx SE and United Therapeutics Corporation Allocate Funds
R&D Insights: How United Therapeutics Corporation and Intra-Cellular Therapies, Inc. Allocate Funds
R&D Insights: How United Therapeutics Corporation and MannKind Corporation Allocate Funds
R&D Spending Showdown: United Therapeutics Corporation vs Iovance Biotherapeutics, Inc.
United Therapeutics Corporation vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: United Therapeutics Corporation and Amphastar Pharmaceuticals, Inc.